Stay updated on Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial
Sign up to get notified when there's something new on the Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial page.

Latest updates to the Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a maintenance or software release without changing the underlying study content.SummaryDifference0.0%

- Check25 days agoChange DetectedRevision updated from v3.5.0 (2026-04-08) to v3.5.2 (2026-04-13).SummaryDifference0.2%

- Check33 days agoChange DetectedAdded update dates 2026-04-08 and 2026-04-09, and removed 2026-04-01 and 2026-04-02 from the study record history; these are maintenance edits that do not modify the trial details or outcomes.SummaryDifference0.1%

- Check40 days agoChange DetectedThe update history shows additions for 2026-04-02 and 2026-04-01 and deletions for 2026-03-25 and 2026-03-24.SummaryDifference0.1%

- Check47 days agoChange DetectedAdministrative updates were made to the study record, adding update dates of 2026-03-24 and 2026-03-25 and removing 2026-03-18 and 2026-03-19. These changes do not alter the study’s core content, eligibility, or outcomes.SummaryDifference0.1%

- Check54 days agoChange DetectedPage revision updated to v3.5.0 with new dates (2026-03-18, 2026-03-19) and removal of earlier updates (2026-03-11, 2026-03-12).SummaryDifference0.2%

Stay in the know with updates to Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial page.